Please: Login/Register

The Latest Edition of "Eyes on malaria" magazine will be out very soon!! | CALL FOR ARTICLES: AMMREN is inviting journalists / writers / scientists interested in reporting on malaria to send articles for publication in its international magazine “Eyes on Malaria” and for posting on its website. Please contact the AMMREN Secretariat for more details click here. Enjoy your stay!. Volunteers and interns urgently needed to work with an NGO working in the area of malaria and health. Apply through - ammren1@gmail.com / ammren1@yahoo.com. Journalists interested in reporting on and writing articles on health issues should please reply through this email: ammren1@gmail.com

ANNOUNCEMENTS:::

TIPS ON MALARIA

  • HOW CAN MOSQUITOES BE CONTROLLED?

    Mosquitoes around the home can be reduced significantly by minimizing the amount of standing water available for mosquito breeding. Residents are urged to reduce standing water around the home in a variety of ways.

  • HOW CAN I PROTECT MYSELF FROM MOSQUITO-BORN DISEASES?

    The best way is to avoid being bitten by mosquitoes.This can be accomplished using personal protecting  while outdoors when mosquitoes are present. Treated bed nets should be used sleeping. Mosquito repellent should be used when outdoor.

  • WHO ARE AT RISK?


    Nearly half of the world’s population is at risk of getting malaria. Pregnant women are particularly at risk of malaria. Children under 5 years are at high risk of malaria.
     

MAGAZINE EDITIONS

  • First Edition

  • Second Edition

  • Third Edition

  • Fourth Edition

  • Fifth Edition

  • Sixth Edition

  • Seventh Edition

  • Eighth Edition

  • Ninth Edition

  • Special Edition

  • INESS Edition

  • Tenth Edition

  • INDEPTH Edition

  • Eleventh Edition

  • Twelfth Edition

  • Special Edition

  • Special Edition

  • Volume 1

Ninth Edition Editorial

The global malaria community is doing the right thing by taking stock of the promises and realities of ending malaria deaths at the targeted 2015.

Reduction of malaria deaths by a third over the last decade in Africa shows that investing in malaria does bring results. It has also shown that these gains are fragile and will be reversed unless malaria continues to be a priority for decision-makers and donors.

These truths cannot be over-emphasized. For that reason, all must support the rallying call of the Roll Back Malaria partnership on World Malaria Day 2012 to "Sustain Gains, Save Lives: Invest in Malaria."

As the experts say “Whether or not the malaria map will keep shrinking, as it has in the past decade, or be reclaimed by the malaria parasites, depends to a great extent, on the resources that will be invested in control efforts over the next years.”

It also stands to reason that we cut our losses by tackling the negative factors holding us back in our quest to eliminate the killer responsible for an estimated 600 thousand deaths a year, mostly in sub-Saharan Africa.

This is why this edition of Eyes on Malaria is focusing on counterfeit drugs as they have proved to be a danger to the success of the fight against malaria and other diseases. 

Powerful stakeholders like the African Leaders Malaria Alliance (ALMA) need to treat fake drug manufacturers and their agents with the same ruthlessness employed against dealers in narcotic drugs.

Obviously, the inability of stakeholders such as drug enforcement agencies, customs officers, the police and drug manufacturing giants to join forces to check this counterfeit problem can lead to a loss of confidence in orthodox medicine and compel people in poor countries to resort to herbal and unconventional solutions whether or not they have been certified to be efficacious.

The fact that even the artemisinin-based combination therapy(ACT) is being faked is worrying indeed.

Equally worrying is the shortfall in the support for the Global Fund at this critical point in time.

We therefore salute the Bill and Melinda Gates Foundation (BMGF), Germany, Japan and other stakeholders for pledging funds to ensure the Global Fund does not cancel the next round of funding for malaria, HIV/AIDS and tuberculosis. This is surely the way to save lives.

Donor fatigue is now a reality and African governments must respond to the situation and commit more funds to help maintain the gains made against malaria and other tropical diseases.

Editorial team

Charity Binka      - Managing Editor
Carlton Cofie       - Editor
Eunice Menka    - Assistant Editor

Editions: 
Ninth Edition